TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Pre-Market Trading 04-09 07:10:29 EDT

0.9300

-0.0500

-5.10%

High1.05	Low0.8645	Vol190.15K
Open1.00	D1 Closing0.9800	Amplitude18.92%
Mkt Cap36.78M	Tradable Cap19.10M	Total Shares39.55M
T/O178.43K	T/O Rate0.93%	Tradable Shares20.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":0.93,"timestamp":1744142400000,"preClose":0.98,"halted":0,"volume":190146,"delay":0,"floatShares":20536698,"shares":39551098,"eps":-1.326523,"marketStatus":"Pre-Market Trading","change":-0.05,"latestTime":"04-09 07:10:29 EDT","open":1,"high":1.0499,"low":0.8645,"amount":178430.0971662,"amplitude":0.189184,"askPrice":1.1,"askSize":100,"bidPrice":0.8634,"bidSize":2316,"shortable":0,"etf":0,"ttmEps":-1.326523,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744205400000},"marketStatusCode":1,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":0.93,"postHourTrading":{"tag":"盘后","latestPrice":0.93,"preClose":0.93,"latestTime":"18:54 EDT","volume":10,"amount":9.3,"timestamp":1744152841005},"volumeRatio":0.3261395312146132,"impliedVol":3.4035,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/TELA","defaultTab":"news","newsList":[{"id":"2523910738","title":"Tela Bio announces U.S. launch of larger sizes of OviTex PRS","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910738","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910738?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:16","pubTimestamp":1743419771,"startTime":"0","endTime":"0","summary":"TELA Bio (TELA) announced the U.S. launch of larger sizes of OviTex PRS Reinforced Tissue Matrix, the only tissue-based device reinforced with poly...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-announces-u-s-launch-of-larger-sizes-of-ovitex-prs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-announces-u-s-launch-of-larger-sizes-of-ovitex-prs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA","PRS"],"gpt_icon":0},{"id":"2523917547","title":"TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917547","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917547?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"The OviTex PRS portfolio now includes a larger option than any human acellular dermal matrix product on the market. MALVERN, Pa., March 31, 2025  -- TELA Bio, Inc. , a commercial-stage medical technology company focused on advancing soft-tissue reconstruction solutions, today announced the U.S. launch of larger sizes of OviTex PRS Reinforced Tissue Matrix, the only tissue-based device reinforced with polymer suture embroidery specifically engineered for plastic and reconstructive surgery.About TELA Bio, Inc.TELA Bio, Inc.  is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tela-bio-announces-u-commercial-110000520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRS","BK4198","TELA"],"gpt_icon":0},{"id":"2521217718","title":"TELA Bio Full Year 2024 Earnings: Revenues Disappoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2521217718","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521217718?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 21:27","pubTimestamp":1742650043,"startTime":"0","endTime":"0","summary":"AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NasdaqGM:TELA Earnings and Revenue Growth March 22nd 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 7.2%. Earnings per share  was mostly in line with analyst estimates.Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Medical Equipment industry in the US.The company's shares are down 37% from a week ago.Before you take the next step you should know about the 3 warning signs for TELA Bio (1 can't be ignored!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tela-bio-full-2024-earnings-132723699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELA"],"gpt_icon":0},{"id":"2521230996","title":"TELA Bio Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2521230996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521230996?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 01:33","pubTimestamp":1742578380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 13:33 ET (17:33 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521325337","title":"TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover","url":"https://stock-news.laohu8.com/highlight/detail?id=2521325337","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521325337?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 01:26","pubTimestamp":1742578001,"startTime":"0","endTime":"0","summary":"TELA Bio (TELA, Financials) shares plunged 43% to $1.33 as of 11:43 a.m. Eastern Time on March 21 after the medical technology company reported a sharp slowdown in fourth-quarter growth and revealed h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2745913/tela-bio-shares-drop-43-after-weak-q4-growth-high-sales-turnover","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["TELA"],"gpt_icon":0},{"id":"2521234083","title":"TELA Bio Is Maintained at Market Outperform by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2521234083","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521234083?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 00:30","pubTimestamp":1742574600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 12:30 ET (16:30 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521809272","title":"Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521809272","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521809272?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 22:14","pubTimestamp":1742566440,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44437037/dow-tumbles-over-400-points-nike-shares-dip-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","TSYW.SI","TELA","PCOM","BK4122","LU2098885051.SGD","YHC","NVIW.SI","BK4566","LU0823411888.USD","BK4192","BK4581","BK4146","BK4561","BK4534","USAW.SI","LU1303367103.USD","ALUR","SQQQ","BK4533","QID","BK4558","BK4585","TQQQ","QLD","MNQmain","IBO","VVPR","BK4009","NKE","DMN","LU0786609619.USD","NQmain","BK4091","BK4133","PSQ","BK4007","BK4588",".IXIC","BK4099","BK4198"],"gpt_icon":1},{"id":"2521284566","title":"Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2521284566","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521284566?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 21:28","pubTimestamp":1742563685,"startTime":"0","endTime":"0","summary":"US stocks look set to open lower in Friday's trading session but are still in a position to close out the week higher for the first time in over a month.The Dow Jones Industrial Average futures were d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSYW.SI","AKA.AU","SDOW","USAW.SI","USJW.SI","PNBK","BK4212","NQmain","ISBC","DOG","IBO",".IXIC","BK4198","TQQQ","BK7095","CFSB",".DJI","ALUR","BK4539","BK4091","BK4099","QLD","DXD","NVIW.SI","AKA","DJX","SQQQ","RNAZ","SOWG","DDM","BK4094","BK4122",".SPX","QID","BK4211","TELA","UDOW","BK4139","MNQmain","BK4007","PSQ","BK4195","DMN","BK4192"],"gpt_icon":1},{"id":"2521289904","title":"Tela Bio price target lowered to $6 from $8 at Lake Street, buy on weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289904?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 21:00","pubTimestamp":1742562010,"startTime":"0","endTime":"0","summary":"Lake Street lowered the firm’s price target on Tela Bio (TELA) to $6 from $8 and keeps a Buy rating on the shares. Tela Bio’s Q4 results were signi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-6-from-8-at-lake-street-buy-on-weakness?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-6-from-8-at-lake-street-buy-on-weakness?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"gpt_icon":0},{"id":"2521283496","title":"Investors Face Another Losing Week as US Futures Lower Slip Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2521283496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521283496?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 20:15","pubTimestamp":1742559345,"startTime":"0","endTime":"0","summary":"US stock futures were tracking lower in Friday's premarket session as Dow Jones Industrial Average futures were down 0.26%, S&P 500 futures were off 0.24%, and Nasdaq futures declined 0.32%.Although a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BRKL","BK4192","ALUR","PNBK","TELA","BK4007","BK4195","ISBC","IBO","BK4198","BK4211","CFSB"],"gpt_icon":1},{"id":"2521283529","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2521283529","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521283529?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 20:14","pubTimestamp":1742559251,"startTime":"0","endTime":"0","summary":"Damon  stock fell 68% in recent Friday premarket activity, a day after pricing a public offering of 126.9 million units at $0.13 apiece.Tela Bio  shares slipped 21% after it posted lower-than-expected Q4 revenue late Thursday and issued Q1 and full-year 2025 revenue outlook that trailed estimates.Planet Labs  stock slipped 10% after reporting overnight a wider fiscal Q4 adjusted net loss.FedEx  shares fell 8% a day after it reported lower-than-expected fiscal Q3 adjusted earnings and revenue and trimmed its fiscal 2025 guidance.Nike  stock was down 7% after reporting overnight lower fiscal Q3 earnings and revenue.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FDX","BK4131","LU1303367103.USD","BK4099","LU2098885051.SGD","LU0742534661.SGD","LU0310800965.SGD","TELA","BK4123","LU0251131958.USD","BK4566","BK4534","LU1267930227.SGD","DMN","BK4146","LU0786609619.USD","BK4588","BK4198","BK4091","LU1571399168.USD","LU0052756011.USD","BK4581","BK4585","BK4558","BK4533","LU0128525689.USD","NKE","LU0823411888.USD","LU0251142724.SGD","PL","LU0048573561.USD","BK4561"],"gpt_icon":1},{"id":"2521283834","title":"Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2521283834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521283834?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 20:05","pubTimestamp":1742558710,"startTime":"0","endTime":"0","summary":"TELA Bio (TELA) has an average rating of buy and mean price target of $6.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TELA"],"gpt_icon":0},{"id":"2521403047","title":"TELA Bio Cut to Neutral From Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403047","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403047?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 18:05","pubTimestamp":1742551500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 06:05 ET (10:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521411472","title":"TELA Bio’s Hold Rating: Challenges in Sales Force Turnover and Financial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2521411472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521411472?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 17:15","pubTimestamp":1742548548,"startTime":"0","endTime":"0","summary":"In a report released yesterday,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/tela-bios-hold-rating-challenges-in-sales-force-turnover-and-financial-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/tela-bios-hold-rating-challenges-in-sales-force-turnover-and-financial-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"gpt_icon":0},{"id":"2521344507","title":"TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2521344507","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521344507?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 06:50","pubTimestamp":1742511006,"startTime":"0","endTime":"0","summary":"TELA Bio, Inc.  came out with a quarterly loss of $0.23 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items.TELA Bio , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $17.65 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 24.25%. This compares to year-ago revenues of $17 million. The company has topped consensus revenue estimates just once over the last four quarters.TELA Bio shares have lost about 21.9% since the beginning of the year versus the S&P 500's decline of -3.5%.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tela-bio-inc-tela-reports-225006491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TELA"],"gpt_icon":0},{"id":"2521949431","title":"TELA Bio Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2521949431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521949431?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 05:01","pubTimestamp":1742504486,"startTime":"0","endTime":"0","summary":"TELA Bio Inc reports results for the quarter ended December 31 - Earnings SummaryTELA Bio Inc TELA.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended December 31, higher","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL8N3Q32D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521499701","title":"TELA Bio Q4 Net Loss Narrows, Revenue Rises; 2025 Sales Outlook Set -- Shares Fall After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2521499701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521499701?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:37","pubTimestamp":1742503046,"startTime":"0","endTime":"0","summary":"TELA Bio  reported a Q4 net loss Thursday of $0.23 per diluted share, compared to a loss of $0.53 a year earlier.One analyst polled by FactSet expected a loss of $0.24.Revenue for the quarter ended Dec. 31 was $17.6 million, up from $17 million a year earlier.Analysts polled by FactSet expected $23.2 million.For Q1, the company has a revenue outlook of $17 million to $18 million. Four analysts expect $21 million.The company expects full-year 2025 revenue between $85 million to $88 million. Analysts expect $93.8 million.Shares fell 24% in recent after-hours activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TELA"],"gpt_icon":0},{"id":"2521960824","title":"TELA Bio Q4 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate, Sales $17.649M Miss $23.166M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521960824","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521960824?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:13","pubTimestamp":1742501637,"startTime":"0","endTime":"0","summary":"TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 56.6 percent increase over losses of $(0.53) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44425117/tela-bio-q4-2024-gaap-eps-0-23-misses-0-22-estimate-sales-17-649m-miss-23-166m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TELA Bio Q4 2024 GAAP EPS $(0.23) Misses $(0.22) Estimate, Sales $17.649M Miss $23.166M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521496909","title":"BRIEF-TELA Bio Q4 Revenue USD 17.649 Million Vs. IBES Estimate USD 23.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496909?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:05","pubTimestamp":1742501146,"startTime":"0","endTime":"0","summary":"Mar 20  - TELA Bio Q4 income from operations USD -8.354 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nPLX634C81:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2521849696","title":"TELA Bio Q4 Basic EPS USD -0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2521849696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521849696?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:05","pubTimestamp":1742501101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nPLX634C81:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":-0.2677},{"period":"1month","weight":-0.6157},{"period":"3month","weight":-0.6804},{"period":"6month","weight":-0.6092},{"period":"1year","weight":-0.8198},{"period":"ytd","weight":-0.6921}],"compareEarnings":[{"period":"1week","weight":-0.115},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.1578},{"period":"6month","weight":-0.1383},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":-0.1529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003302},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003028},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.21226},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.063104},{"month":5,"riseRate":0.8,"avgChangeRate":0.052642},{"month":6,"riseRate":0.4,"avgChangeRate":-0.006439},{"month":7,"riseRate":0.2,"avgChangeRate":-0.020639},{"month":8,"riseRate":0.4,"avgChangeRate":-0.044713},{"month":9,"riseRate":0.6,"avgChangeRate":-0.01682},{"month":10,"riseRate":0.4,"avgChangeRate":-0.050729},{"month":11,"riseRate":0.4,"avgChangeRate":-0.001312},{"month":12,"riseRate":0.5,"avgChangeRate":0.082086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}